Raloxifene hydrochloride (RLX) was provided by Aarti Drugs Ltd. (New Delhi, India) while naringin hydrate (NRG) and KBr were obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan).
Labrasol®,
Labrafac®,
Precirol ATO5®, Transutol
®,
Labrafil®,
Caproyl 90®,
Capmul MCM®,
Gelucire 50/13®,
Gelucire 48/16®, and
Compritol 888 ATO® were generously provided by Gattefosse (Saint-Priest, France). Soyabean oil, peanut oil, sesame oil, corn oil,
glyceryl monostearate, and sunflower oil were purchased from Loba Chemie (Chennai, India).
Methanol,
acetonitrile,
ethyl oleate,
PEG 400, Tween 80
®, D-mannitol, methylene chloride, and
hydrochloric acid were received from Central Drug House Pvt. Ltd. (Chennai, India). Almond oil, olive oil, castor oil, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) were obtained from SRL Pvt. Ltd. (Chennai, India).
Oleic acid,
rhodamine B, and
stearic acid were received from Sigma-Aldrich (New Delhi, India). The other materials utilized in this work were of standard analytical quality and used as received from their commercial source.
Alhalmi A., Amin S., Khan Z., Beg S., Al kamaly O., Saleh A, & Kohli K. (2022). Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies. Pharmaceutics, 14(9), 1771.
